Angiogenesis and the heart: Therapeutic implications

Journal of the Royal Society of Medicine

Volumn 90, Issue 6, 1997, Pages 307-311

  Hariawala, Mukesh D ^a   Sellke, Frank W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; HEART; HEART MUSCLE ISCHEMIA; HUMAN; MYOCARDITIS; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SWINE;

EID: 0030873649     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107689709000604     Document Type: Review

References (40)

1. Goldman E. The growth of malignant disease in man and the lower animals with special reference to the vascular system. Lancet 1907;ii:1236
2. Folkman J. Angiogenesis - retrospect and outlook. In: Steiner R, Weisz PB, Langer R, eds. Angiogenesis: Key Principles Science Technology Medicine. Basel: Birkhauser Verlag, 1992:4-13
3. Gimbrone MA Jr, Cotran R, Leapman S, Folkman J. Tumor growth neovascularization: an experimental model using rabbit cornea. J Natl Canc Inst 1974;52:413-27
4. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin-affinity; purification of a tumor-derived capillary endothelial cell growth factor. Science 1984;23:1296-9
5. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235: 442-7
6. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor for angiogenesis. J Expl Med 1971;133:275
7. Schaper W, Vandesteene R. The rate of growth of interarterial anastomosis in chronic coronary artery occlusion. Life Sci 1967;6:1673
8. Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circulation Res 1996;79:911-19
9. Roth DM, Mauoka Y, Rogers J, White FC, Longhurst JC, Bloor CM. Development of coronary collateral circulation in left circumflex ameroid-occluded swine myocardium. Am J Physiol 1987;253:H1259-88
10. Roth DM, White FC, Bloor CM. Altered minimal coronary resistance to antegrade reflow after chronic coronary artery occlusion in swine. Circulation Res 1988;63:330-9
11. Bloor CM, White FC, Sanders TM. Effects of exercise on collateral development in myocardial ischemia in pigs. J Appl Physiol 198456:656-65
12. Roth DM, White FC, Nichols ML, Dobbs SL, Longhurst JC, Bloor CM. Effect of long-term exercise on regional myocardial function and coronary collateral development after gradual coronary artery occlusion in pigs. Circulation 1990;82:1778-89
13. Chilian WM, Mass HJ, Williams SE, Layne SM, Smith ES, Scheel KW. Microvascular occlusions promote coronary collateral growth. Am J Physiol 1990;258:H1103-11
14. More JWI, Sholley MM. Comparison of the neovascular effects of stimulated macrophages and neutrophils in autologous rabbit corneas. Am J Pathol 1985;120:87-98
15. Sunderkotter C, Goebeler M, Schulze Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther 1991;51:195-216
16. Fujita M, Ikemoto M, Kishishita M, et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 1996,94:610-13
17. Klagsbrun M, D'More PA. Regulators of angiogenesis. Annu Rev Physiol 1991;53:217-39
18. Ishikawa F, Miyazono K, Hellman U, et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338:557-62
19. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, flt-1 expression in a rat model myocardial infarction model of angiogenesis. Am J Physiol 1996;270:H1803-11
20. Sellke FW, Wang SY, Stamler A, Lopez JJ, Li J, Li JY, Simons M. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic myocardium. Am J Physiol 1996;271:H713-20
21. Ziche M, Morbidelli L, Masani E, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994;94:2036-44
22. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996;270:H411-15
23. Hawker JR, Granger HJ. Tyrosine kinase inhibitors impair fibroblast growth factor signalling in coronary endothelial cells. Am J Physiol 1994;266:H107-H120
24. Wu HM, Yuan Y, McCarthy M, Granger HJ. Acidic and basic FGF's dilate arterioles of skeletal muscle through a NO-dependent mechanism. Am J Physiol 1996;271:H1087-93
25. Pipili-Synetos E, Papageorgiou A, Sakkoula E, et al. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 1995;116;1829-34
26. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401-3
27. Harada K, Grossman W, Friedman M, et al. Basic fibroblast growth factor improved myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994;94:623-30
28. Lazarous DF. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 1995;91:145-53
29. Unger EF, Banai S, Shou M, Jaklitsch M, Hodge E, Correa P, et al. A model to assess interventions to improve collateral blood flow: continuous administration of agents into the left coronary artery in dog. Cardiovasc Res 1993;27:785-91
30. Lopez J, Edelman ER, Stamler A, Thomas KA, DiSalvo J, Hibberd MG, et al. Perivascular delivery of prolonged half life aFGF via EV Ac results in angiographic collateral development, improvement in coronary flow and function in chronic myocardial ischemia (abstr). J Am Coll Cardiol 1996;27:30A
31. Hariawala MD, Horowitz JR, Esakoff D, et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 1996;63:77-82
32. Banai S, Jaklitsch MT, Shou M, et al.. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-89
33. Harada K, Friedman M, Lopez JJ, et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 1996;270:H1791-802
34. Giordano FJ, Ping P, McKirnan MD, Nozaki S, DeMaria AN, Dillman WH, et al. Intracoronary transfer of fibroblast growth factor 5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med 1996;2:534-9
35. Harrison DG, Chilian WM, Marcus ML. Absence of functioning alpha-adrenergic receptors in mature canine coronary collaterals. Circulation Res 1986;59:133-42
36. Sellke FW, Wang SY, Friedman M, Harada K, Edelman ER, Grossman W, et al. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am J Physiol 1994;267:H1303-11
37. Sellke FW, Wang SY, Friedman M, et al. Beta-adrenergic modulation of the colateral-dependent coronary microcirculation. J Surg Res 1995;59:185-90
38. Isner JM, Pieczek A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of ph VEGF165 in patient with ischemic limb. Lancet 1996;348;370-4
39. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nature Med 1997;3:158-64
40. Asahara T, Bauters C, Zheng LP, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995;92:II-365